At ASTRO 2026, Dr. Nitin Ohri details additive versus synergistic toxicities when combining radiation with novel systemic therapies in clinical trials.
|Videos|August 21, 2017
Head and Neck Lymphedema Is More than a Cosmetic Problem
Author(s)Jan S. Lewin, PhD
Jan Lewin, PhD, section chief of Speech Pathology at the University of Texas MD Anderson Cancer Center, discusses head and neck lymphedema.
Advertisement
Jan Lewin, PhD, section chief of Speech Pathology at the University of Texas MD Anderson Cancer Center, discusses head and neck lymphedema.
Most people are familiar with lymphedema of the arms or legs, but head and neck lymphedema is discussed far less often. However, for patients who develop the condition, it can be very debilitating, and is a problem that is more than just cosmetic, Lewin says.
Advertisement
Related to this article
APHON 2026 speaker Amy C. Haskamp, CNS, discusses tiered self-care tactics and boundaries to help pediatric oncology nurses navigate emotional distress and burnout.
At ASTRO 2026, DJohn Hillson details how early post-surgical radiation education within 6 weeks improves outcomes for head and neck cancer patients.
Jyoti Malhotra, MD, MPH, joins The Moonlight Shift to discuss first-in-human phase 1 lung cancer trials, healthcare access, and her work at Yale Cancer Center.
Vanderbilt APPs discuss PSA screening, multidisciplinary care, toxicity management, and genetic testing for Prostate Cancer Awareness Month.
ANA President Jennifer Mensik Kennedy outlines systemic nurse fatigue mitigation policies, emphasizing patient safety and acuity across oncology care.
Co-developed by NYU Langone and Dana-Farber, the Solavia platform integrates EHR workflows, decision support, and pathway tracking for APPs and PAs.
The FDA expands accelerated approval for sevabertinib to frontline HER2-mutant NSCLC, highlighting a need for vigilant nursing management of diarrhea.
Advertisement
Advertisement